One-month atogepant treatment induces rapid changes in delta-band functional connectivity in migraine: an HD-EEG study
{{output}}
Background: Atogepant is a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for the preventive treatment of migraine. While its peripheral mechanisms are well characterized, little is known about its... ...
